Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial ENaC as a repressor of oxidative stress and a guardian of lung capillary barrier function in bacterial and viral pneumonia.

Frontiers in physiology·2025
Same author

Give us a hand, mate! A holistic review of research on human-machine teaming.

BMJ military health·2024
Same author

The clinical spectrum of HbSC sickle cell disease-not a benign condition.

British journal of haematology·2024
Same author

Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase-III trials and the real-life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Immobilization of biotinylated antibodies through streptavidin binding aptamer.

Talanta·2023
Same author

Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease.

Frontiers in health services·2023

Related Experiment Video

Updated: Jul 25, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Stroke prevention trial in sickle cell anemia

R J Adams1, V C McKie, D Brambilla

  • 1Department of Neurology, Medical College of Georgia, Augusta 30912-3200, USA.

Controlled Clinical Trials
|March 11, 1998
PubMed
Summary

Preventing first-time stroke in children with Sickle Cell Disease (Hb SS) is crucial. The Stroke Prevention Trial in Sickle Cell Anemia (STOP) investigates if blood transfusions guided by Transcranial Doppler (TCD) ultrasound can significantly reduce stroke risk.

More Related Videos

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Related Experiment Videos

Last Updated: Jul 25, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
08:23

Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

Published on: November 5, 2019

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Vascular Medicine

Background:

  • Stroke is a significant cause of morbidity in children with Sickle Cell Disease (Hb SS).
  • While chronic blood transfusions reduce stroke recurrence, primary prevention of a first stroke is essential to prevent irreversible brain injury.
  • Transcranial Doppler (TCD) ultrasound identifies children at high risk for stroke based on blood flow velocity.

Purpose of the Study:

  • To evaluate the effectiveness of periodic blood transfusions in reducing the risk of first-time stroke in children with Hb SS.
  • To determine if reducing sickle hemoglobin levels to ≤30% via transfusion can decrease stroke incidence by at least 70% compared to standard care.
  • To assess the impact of transfusions on asymptomatic brain lesions detected by MRI/MRA.

Main Methods:

  • The multi-center Stroke Prevention Trial in Sickle Cell Anemia (STOP) randomized children with Hb SS to receive either blood transfusions or standard care.
  • Screening involved standardized Transcranial Doppler (TCD) ultrasound and Magnetic Resonance Imaging/Angiography (MRI/MRA) protocols.
  • Primary endpoints included clinically evident cerebral infarction or intracranial hemorrhage, with blinded adjudication.

Main Results:

  • A time-averaged mean velocity of ≥200 cm/sec on TCD is associated with a 46% risk of cerebral infarction over 39 months.
  • The study is powered to detect a 70% reduction in the primary endpoint with 90% power.
  • Standardized TCD and MRI/MRA protocols with blinded interpretation and endpoint adjudication are key trial features.

Conclusions:

  • This trial aims to establish whether blood transfusions are effective in the primary prevention of stroke in children with Hb SS.
  • Findings will inform future research into cerebrovascular disease and optimize treatment strategies for Hb SS.
  • The study's design addresses the critical need for primary stroke prevention in this vulnerable pediatric population.